Plethico Pharmaceuticals (Delisted) share price history

BSE: 532739

Last traded ₹9.05 on 13 Jun 2016

Delisted on 11 May 2018.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

May 2018
- 18 May · Delisting
  Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957, it has been decided to delist (withdraw the admission to dealings in) equity shares of the Plethico Pharmaceuticals Limited w.e.f. May 30, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009. (opens in a new tab)
Feb 2018
- 28 Feb · Public Notice - Compulsory Delisting
  Members of the Exchange are hereby informed that the Exchange on February 28, 2018 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements). (opens in a new tab)
Jul 2016
- 25 Jul · Shareholding for the Period Ended June 30, 2016
  Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
- 22 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation .... (opens in a new tab)
May 2016
- 10 May · Management
  Company has received a resignation letter from the Director Ms. Meena Matani.
- 10 May · Management
  Company has received a resignation letter from the Director Ms Meena Matani. (opens in a new tab)

Results

Standalone; ₹ crore, the charts by years to December, then March, the table by quarter. No standalone results on record for the years to Dec 2010 and Mar 2014.Quarterly results

Quarter to Mar 2015, against the quarter before

Revenue: ₹13 Crdown 36.19%
Net profit: −₹243 CrQuarter to Dec 2014: −₹12 Cr
Net margin: −1,845.8%

Revenue by year

Peak revenue ₹540 Cr, year to Dec 2008

Net profit by year, a loss in red

Net profit
Loss

A loss in 3 of the 5 years with results on record

The company moved its year end from December to March: its last year to December on record ended in Dec 2012, its first year to March in Mar 2015.

₹ crore	Jun 2013	Sep 2013	Dec 2013	Mar 2014	Jun 2014	Sep 2014	Dec 2014	Mar 2015
Revenue	184	137	76	62	53	50	21	13
Net profit	3	2	−7	−8	−11	−7	−12	−243
Net margin	1.5%	1.2%	−8.9%	−13.7%	−20.4%	−14.5%	−59.9%	−1,845.8%

Standalone. The last eight quarters. The latest is shaded.

Where the return came from

Yearly rates to Mar 2015, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	−35.4%	–	–	0.0%
3 years	−57.7%	–	–	0.0%
5 years	−41.5%	–	–	0.0%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

Plethico Pharmaceuticals share price by year

Each calendar year to 2016.

Year	Close at year end	Change	Highest close	Lowest close
2016BSE close	9.05	−31.4%	14.50	7.97
2015	13.20	−63.9%	42.60	10.95

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2016 close is its last trade, on 13 Jun 2016.

Recent sessions

The last 10 trading days to 13 Jun 2016, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
13 Jun 2016	9.05	9.05	9.05	9.05	9.05	200
6 Jun 2016	9.50	9.50	9.50	9.50	9.50	110
30 May 2016	8.00	8.69	7.97	7.97	8.01	10,741
23 May 2016	8.39	8.39	7.90	8.38	8.33	3,700
16 May 2016	8.70	8.70	7.99	8.04	8.11	12,827
9 May 2016	9.95	9.95	9.95	9.95	9.95	285
2 May 2016	10.45	10.45	10.45	10.45	10.45	152
25 Apr 2016	10.95	10.95	10.95	10.95	10.95	235
18 Apr 2016	8.78	8.78	8.74	8.74	8.75	19,773
11 Apr 2016	8.74	9.44	8.72	9.20	8.88	7,654

Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-date	Event	Price factor	What happened
25 Apr 2016	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
11 Apr 2016	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
21 Mar 2016	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
14 Mar 2016	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
21 Aug 2012	Price move	–	Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for.
25 Aug 2009	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.

Each event is noted and not adjusted for.

Company details

Legal name: Plethico Pharmaceuticals Ltd.
BSE code: 532739
ISIN: INE491H01018
Listed: May 2006
Face value: ₹10
Former symbols: PLETHICO
Website: www.plethico.com (opens in a new tab)
CIN: L24232MP1991PLC006801; Corporate identity number, the registrar of companies' code for it

Last announcements

May 2018

Feb 2018

Jul 2016

May 2016

Share price history

Daily close, ₹ per share